Postolenko, Olena – Trademark Portfolio

Entity Type: 01

Postolenko, Olena holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include BTQ BIOTEQUE LAB. The owner is based in Ostapivka.

lane Poshtovyi, 6

area Mykolaivska, Arbuzynskyi

Ostapivka 55331 , UA

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Postolenko, Olena's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Postolenko, Olena have?

Postolenko, Olena has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 2 abandoned.

What trademark classes does Postolenko, Olena file in?

Postolenko, Olena files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Postolenko, Olena's most well-known trademarks?

Postolenko, Olena's registered trademark portfolio includes well-known marks such as BTQ BIOTEQUE LAB. These are among 1 currently registered trademark in the portfolio.

What is Postolenko, Olena's trademark registration success rate?

Postolenko, Olena has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.